Akanda Corp.

AKAN

Healthcare

Akanda Corp.

Drug Manufacturers - Specialty & Generic

$51.58
+2.62 (+5.35%)
$51.58+5.35%
Feb 2Feb 4Feb 6Feb 10Feb 12Feb 17Feb 19Feb 24Feb 27Mar 3Mar 5Mar 9Mar 11Mar 13Mar 18Mar 23Mar 26Mar 31Apr 2Apr 7Apr 9Apr 13Apr 15Apr 17Apr 21Apr 23Apr 28May 1$2$17$32$51
Key events (≥5% daily moves)
Up dayDown day
About This Company

Akanda Corp. is a healthcare company focused on the cannabis industry. It grows, produces, and sells cannabis products, specifically aiming for the medical and wellness markets. The company operates in the United Kingdom, Lesotho, and other international locations, working to supply these specialized cannabis products.

https://www.akandacorp.com
Key Statistics
Open$57.72
Day High$78.90
Day Low$44.75
Prev. Close$48.96
$209.23
$2.30
$1.67M
7.08M
1.73
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
46
Country
GB
IPO Date
2022-03-15
Exchange
NASDAQ
$2.30
52W Low
$51.58
Current
$209.23
52W High
Catalysts & Risks
Catalysts
  • Successful clinical trials or regulatory approvals for new specialty drug formulations or generic equivalents, expanding product pipeline.
  • Strategic partnerships or acquisitions that broaden market reach, enhance manufacturing capabilities, or provide access to new intellectual property.
  • Increased demand for specific generic or specialty drugs due to market shortages, patent expirations of branded drugs, or favorable healthcare policy changes.
  • Improved financial performance driven by cost efficiencies, higher sales volumes, or better pricing power for existing products.
Risks
  • Intense competition from larger pharmaceutical companies and other generic manufacturers, leading to price erosion and market share loss.
  • Regulatory hurdles, including delays in drug approvals, stricter manufacturing standards, or changes in healthcare reimbursement policies.
  • Reliance on a limited number of key products or active pharmaceutical ingredients (APIs), making the company vulnerable to supply chain disruptions or product failures.
  • Litigation risks related to patent infringement, product liability, or regulatory non-compliance, which could result in significant financial penalties or operational disruptions.

AI-generated · For informational use only

Own this stock?

Add it to your portfolio to track your performance.